Science & Technology

Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients

Department of Health and Human Services — National Institutes of Health

Opportunity #: 2R44DK127658-04

Award Ceiling

$857K

Award Floor

$857K

Close Date

Aug 31, 2028

900 days left

Total Funding

$857K

Expected Awards

Posted Date

Sep 16, 2025

Cost Sharing Required

Grants.gov ID

sbir-2R44DK127658-04

Description

SBIR Phase Phase II award: "Outcomes study for the XL1 distraction enterogenesis device to improve nutrient absorption in short bowel syndrome patients" awarded to ECLIPSE REGENESIS, INC. in MOUNTAIN VIEW, California. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $856,731. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.